ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Immunity, Mucosal

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Biological Phenomena, Cell Phenomena, and Immunity ∟ Immunity ∟ Immunity, Mucosal 29 coordinate concepts ∟ Antibody Diversity \| ∟ Antibody Formation \| ∟ Antibody Specificity \| ∟ Antibody-Dependent Enhancement \| ∟ Antigen-Antibody Reactions \| ∟ Autoimmunity \| ∟ CD4-CD8 Ratio \| ∟ Complement Activation \| ∟ Cross-Priming \| ∟ Cytotoxicity, Immunologic \| ∟ Dose-Response Relationship, Immunologic \| ∟ Histamine Release \| ∟ HIV Seronegativity \| ∟ Immune Tolerance \| ∟ Immunity, Active \| ∟ Immunity, Cellular \| ∟ Immunity, Herd \| ∟ Immunity, Maternally-Acquired \| ∟ Immunity, Natural \| ∟ Immunocompetence \| ∟ Immunocompromised Host \| ∟ Immunogenetics \| ∟ Immunologic Memory \| ∟ Lymphocyte Cooperation \| ∟ Neuroimmunomodulation \| ∟ Neutrophil Activation \| ∟ Neutrophil Infiltration \| ∟ T-Cell Antigen Receptor Specificity \| ∟ Tumor Escape X
Broader terms:	Medical Subject Headings (MeSH) ∟ Biological Phenomena, Cell Phenomena, and Immunity ∟ Immunity ∟ Immunity, Mucosal Immunity > Biological Phenomena, Cell Phenomena, and Immunity > Medical Subject Headings (MeSH) X
Annotation:	IM general only, NIM with specific disease /immunol (IM) X
History note:	Intestinal Mucosa/immunology (1976-1995) \| Mucous Membrane/immunology (1970-1995)X
historyNote*:	96 X
publicMeSHNote*:	96 X
Scope note:	Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body. X
activeMeSHYear*:	2002 \| 2003 \| 2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1995-02-17X
dateEstablished*:	1996-01-01X
dateRevised*:	2001-08-03X
recordAuthorizer*:	sjnX
recordMaintainer*:	sjnX
recordOriginator*:	AGSX
Related term:	Immunoglobulin A, Secretory X
Type:	Concept X
Coordinate terms:	Antibody Diversity \| Antibody Formation \| Antibody Specificity \| Antibody-Dependent Enhancement \| Antigen-Antibody Reactions \| Autoimmunity \| CD4-CD8 Ratio \| Complement Activation \| Cross-Priming \| Cytotoxicity, Immunologic \| Dose-Response Relationship, Immunologic \| Histamine Release \| HIV Seronegativity \| Immune Tolerance \| Immunity, Active \| Immunity, Cellular \| Immunity, Herd \| Immunity, Maternally-Acquired \| Immunity, Natural \| Immunocompetence \| Immunocompromised Host \| Immunogenetics \| Immunologic Memory \| Lymphocyte Cooperation \| Neuroimmunomodulation \| Neutrophil Activation \| Neutrophil Infiltration \| T-Cell Antigen Receptor Specificity \| Tumor Escape X
URI:	X
Labels and equivalent concepts:	Limakalvoimmuniteetti (fi) Slemhinneimmunitet (sv) Mucosal Immunity (en, replaced) X
Share:	X